CD4 and pneumocystosis: In HIV/AIDS patients with PCP/tuberculosis coinfections and CD4<200cells/ul, ART was initiated within 2-4 weeks after starting TB treatment recommended by National Free Antiretroviral Treatment Program (NFATP) in China before 2016, while ART was initiated within 2 weeks after starting TB treatment in patients with CD4 <50cells/ul and within 2-8 weeks in patients with CD4 >50cells/ul recommended by US HAART guideline after 2016 [16].